Arcutis Biotherapeutics (ARQT) Q1 2026 earnings call recap: ZORYVE sales, 2026 revenue guidance, payer trends, GTN outlook, and pipeline updates—read now.
Arcutis outlines $480M-$495M 2026 revenue guidance while expanding ZORYVE sales teams
Source: Seeking Alpha
Read Full Story →
![[News Today] Fire-hit ship to arrive in Dubai](https://news.kbs.co.kr/data/fckeditor/vod/2026/05/07/169721778168015945.png)